FDA Asks for Voluntary Recall of Popular Generic Antidepressant

J B Reed/Bloomberg News(NEW YORK) — The FDA’s reversal earlier this week of its approval of a generic equivalent of the popular antidepressant Wellbutrin XL 300 ends a five-year saga that began with consumer complaints and a crusade by Joe Graedon, th…

October 4, 2012No CommentRead More